These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9519615

  • 1. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN, Kumar S, Jain S, Bhattacharya SN.
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP, Antia NH.
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract] [Full Text] [Related]

  • 4. Dapsone syndrome: an incomplete form.
    Jaswal R, Thami GP, Kanwar AJ.
    Indian J Lepr; 1998 Jun; 70(2):229-30. PubMed ID: 9724867
    [No Abstract] [Full Text] [Related]

  • 5. Facial reversal reaction: a dermatological emergency.
    Marzano AV, Tosi D, Cusini M, Nunzi E, Massone C, Crosti C.
    J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
    [No Abstract] [Full Text] [Related]

  • 6. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ, Gilson RT, Elston DM.
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [Abstract] [Full Text] [Related]

  • 7. Borderline tuberculoid leprosy developing in a pure neuritic case.
    Porichha D, Mahapatra DC.
    Indian J Lepr; 1991 Apr; 63(2):235-7. PubMed ID: 1783794
    [No Abstract] [Full Text] [Related]

  • 8. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D, López-García L, Neme-Yunes Y, Yuen-Palos R, Vega-Memije ME, Arenas R.
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract] [Full Text] [Related]

  • 9. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 10. Leprosy in a preschool child--a case report.
    Arora SK.
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [Abstract] [Full Text] [Related]

  • 11. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R, Pai VV, Shroff HJ, Gandewar K.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract] [Full Text] [Related]

  • 12. Primary hyperpigmented palmar lesion: a rare presentation of borderline tuberculoid leprosy.
    Grover S, Singh G, Dash K.
    Indian J Lepr; 1997 Jun; 69(2):191-3. PubMed ID: 9290973
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 14. Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
    Ravindra K, Sugareddy, Ramachander T.
    Indian J Lepr; 2010 Sep; 82(2):91-3. PubMed ID: 21434512
    [Abstract] [Full Text] [Related]

  • 15. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN.
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract] [Full Text] [Related]

  • 16. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 17. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A, Khopkar U, Pai VV, Ganapati R.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract] [Full Text] [Related]

  • 18. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S, Reddy R.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract] [Full Text] [Related]

  • 19. Lupus vulgaris and borderline tuberculoid leprosy: an interesting co-occurrence.
    Rao GR, Sandhya S, Sridevi M, Amareswar A, Narayana BL, Shantisri.
    Indian J Dermatol Venereol Leprol; 2011 Mar; 77(1):111. PubMed ID: 21220903
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.